Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-10-15 | 2020-11-07 | 126519 |
TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2020-10-15 | 2020-10-30 | 126527 |
PORTIA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126530 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2020-10-22 | 2020-10-30 | 126915 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-22 | 2021-01-07 | 126939 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
TEVA-VARENICLINE | 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126951 |
TEVA-VARENICLINE | 0.5MG 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126955 |
TEVA-CHLORPROMAZINE | 100MG | TABLET | Resolved | 2020-10-30 | 2020-11-26 | 127604 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Resolved | 2020-10-30 | 2021-02-12 | 127622 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2020-10-30 | 2020-12-03 | 127625 |
TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 127995 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |